Biological Information | |
---|---|
Background Information: | Eph family tyrosine kinase receptors consist of two groups: EphA group members respond to ephrin-A, which is anchored to the cell membrane by glycosylphosphatidylinositol, whereas EphB group members respond to ephrin-B, containing a transmembrane domain. Among them, only EPA4 (EphA4, Ephrin type-A receptor 4, Tyrosine-protein kinase receptor SEK, Receptor protein-tyrosine kinase HEK8) can cross-respond to both ephrin-A and -B. In the final stages of embryogenesis, expression of EphA4 is found predominantly within regions of the central nervous system including the cerebral cortex, striatum, thalamus, hippocampus, and ventral spinal cord. EphA4 null mutant mice showed specific defects in the corticospinal tract. Recently, the Eph-ephrin system has been found to be involved in vascular development, angiogenesis, tumor growth and metastasis as well as regulation of smooth muscle contractility, onset of platelet aggregation and to promote onset, growth and stability of the hemostatic plugs. Inhibition of EPA4 may be used in the treatment of various tumors but may delay wound healing.
GenBank NM_004438 |
Target Class: | Kinase |
Family: | Receptor Typosine Kinase (RTK): Growth Factor Receptor |
Accession Number: | NM_004438.3 |
Target Name: | EphA4 |
Target Aliases: | EPHA4, Hek8, HEK8, EphA4, TYRO1, SEK |
Target Species: | Human |
Usage | |
Product Type: | Enzymes |
Application: | Drug Discovery & Development |
Storage Conditions: | 6 months at -70°C |
Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
Datasheets
14-574x Datasheet
View Document